⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29002294 | 1.00 | KDM1A (0.39) | — | |
| SCHEMBL18571425 | 1.00 | KDM1A (0.39) | — | |
| SCHEMBL29002302 | 1.00 | KDM1A (0.39) | — | |
| SCHEMBL6014401 | 1.00 | — | — | |
| SCHEMBL6014655 | 1.00 | KDM1A (0.39) | — | |
| SCHEMBL2486743 | 1.00 | — | — | |
| SCHEMBL14210854 | 1.00 | KDM1A (0.39) | — | |
| SCHEMBL15904034 | 1.00 | — | — | |
| SCHEMBL6014657 | 1.00 | KDM1A (0.39) | — | |
| SCHEMBL29002315 | 1.00 | KDM1A (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2018147660-A1 | DRUG DRUG DELIVERY FORMULATION FOR TREATING MENTAL ILLNESS OR CENTRAL NERVOUS SYSTEM DISORDER | 아주대학교산학협력단 | 2018-08-16 | — | — | WO | claimed |
| EP-0128006-A2 | A soil-disease-controlling agent | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1984-12-12 | — | — | EP | claimed |
| WO-2019216744-A2 | INJECTION FORMULATION COMPOSITION FOR USE AS FILLER OR DRUG CARRIER THROUGH CLICK CHEMISTRY REACTION | 아주대학교 산학협력단 (KR) | 2019-11-14 | — | — | WO | disclosed |
| WO-2018147660-A1 | DRUG DRUG DELIVERY FORMULATION FOR TREATING MENTAL ILLNESS OR CENTRAL NERVOUS SYSTEM DISORDER | 아주대학교산학협력단 | 2018-08-16 | — | — | WO | disclosed |
| EP-3313944-A1 | TWO-COMPONENT BIOINK, 3D BIOMATERIAL COMPRISING THE SAME AND METHOD FOR PREPARING THE SAME | Ajou University Industry-Academic Cooperation Foundation (KR) | 2018-05-02 | — | — | EP | disclosed |
| WO-2016209062-A1 | TWO-COMPONENT BIOINK, 3D BIOMATERIAL COMPRISING THE SAME AND METHOD FOR PREPARING THE SAME | AJOU UNIVERSITY INDUSTRY-ACADEMIC COOPERATION FOUNDATION (KR) | 2016-12-29 | — | — | WO | disclosed |
| US-7078406-B2 | Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes | JOHNSON & JOHNSON PHARMACEUTICAL RESEARCH & DEVELOPMENT, L.L.C. (US) | 2006-07-18 | — | — | US | disclosed |
| US-6960640-B2 | Composition for optical material | MITSUBISHI GAS CHEMICAL CO., LTD. (JP) | 2005-11-01 | — | — | US | disclosed |
| US-20040248851-A1 | Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes | Life Technologies Corporation | 2004-12-09 | — | — | US | disclosed |
| US-6815445-B2 | FOR USE AS FLUORESCENCE DYES AND PROBES | Life Technologies Corporation | 2004-11-09 | — | — | US | disclosed |
| EP-1442027-A1 | SUBSTITUTED DIPHENYLOXAZOLES, THE SYNTHESIS THEREOF, AND THE USE THEREOF AS FLUORESCENCE PROBES | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 2004-08-04 | — | — | EP | disclosed |
| US-20040147708-A1 | Composition for optical material | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2004-07-29 | — | — | US | disclosed |
| EP-1426392-A1 | COMPOSITION FOR OPTICAL MATERIAL | MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) | 2004-06-09 | — | — | EP | disclosed |
| US-20030105111-A1 | Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes | 3-DIMENSIONAL PHARMACEUTICALS, INC. | 2003-06-05 | — | — | US | disclosed |
| WO-2003031419-A1 | SUBSTITUTED DIPHENYLOXAZOLES, THE SYNTHESIS THEREOF, AND THE USE THEREOF AS FLUORESCENCE PROBES | 3-DIMENSIONAL PHARMACEUTICALS, INC. (US) | 2003-04-17 | — | — | WO | disclosed |
| US-4955901-A | HYDROPHILIC SURFACE TREATMENT | CANON KABUSHIKI KAISHA (JP) | 1990-09-11 | — | — | US | disclosed |